CASE CCC IN THE NEWS
Tamoxifen Resistance in Breast Cancer Patients May Have Mutated Gene to Blame, Research Shows
Plain Dealer - Nov 11, 2013
Researchers have discovered a mutated version of the estrogen receptor, the presence of which may explain why the drug tamoxifen (brand names: Novaldex and Soltamox) is no longer effective in some patients being treated for ER-positive breast cancer. The findings were published online today in Cancer Research, a journal of the American Association for Cancer Research...That five of the metastasized samples had a mutated receptor is more than just chance alone, said Dr. Lyndsay Harris, director of the Breast Cancer Program at University Hospitals Seidman Cancer Center and professor at Case Western Reserve University School of Medicine, who called the findings significant.
What Our Patients Can Teach Us
New York Times - Nov 7, 2013
Dr. Mikkael Sekeres offers another perspective on rising health care costs.
Molecular Imaging: Better Training is Key
Medical Physics Web - Oct 18, 2013
Molecular imaging has vast potential to improve healthcare in the coming years by allowing more directed, personalized therapy. But molecular imaging's contribution may be limited until more imaging specialists are trained to interpret scans acquired with the new types of tracers being developed...Neurobiology and neuroscience are among the disciplines expected to benefit from molecular imaging, said James Basilion, professor of radiology, biomedical engineering, and pathology at Case Western Reserve University in Cleveland. He also sees molecular imaging making inroads in cardiovascular disease for identifying vulnerable plaque.
Case Comprehensive Cancer Center Call for Applications
The Case Comprehensive Cancer Center has released the following pilot grant funding opportunities:
- Pilot Grants: Opportunities for Developing Patient-Derived Xenografts will support the development of patient-derived tumor xenografts (PDX) that will benefit collaborative, multi-investigator projects within the Cancer Center. This RFA is open to all Cancer Center members, regardless of institution.
Deadline: November 15
- Pilot Grants: Use of Tumor Genomic Evaluation for Clinical Decision-Making will provide seed money to foster collaborations and promote and increase institution-wide capacity and competitiveness in the use of tumor genomic evaluation for clinical decision-making. Case CCC members with faculty appointment at all levels (eligible to apply for independent nationally competitive research grants) are encouraged to apply. Proposals from both junior and senior investigators are encouraged. Research proposals must involve patients and/or their tissues.
Deadline: December 2
- Pilot Grants: Planning for Multi-Investigator Proposals will provide funding to further the important goal of facilitating successful applications for large multi-investigator grants (e.g., P01, P50, U54) in the current funding cycle. Applicants must demonstrate they are in communication with appropriate NIH administration, other structures within NIH, or other funding agencies (e.g., formal invitation, preparatory meeting, LOI and/or positive response to RFA or PA). Applicants must be Cancer Center members with faculty appointments, demonstrate intent to apply for national funding within a defined timeline, and describe new research that could not be achieved without the collaboration.
AACR-Aflac Inc. Career Development Award for Pediatric Cancer Research
The AACR-Aflac Inc. Career Development Award for Pediatric Cancer Research represents a joint effort to encourage and support junior faculty who are in the first five years of a faculty appointment (at the start of the grant term) to conduct pediatric cancer research and establish successful career paths in this field. The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to pediatric cancer.
Deadline: December 11
AACI Translational Cancer Research Fellowship
The Case Comprehensive Cancer Center may nominate ONE candidate for the AACI Translational Cancer Research Fellowship. The intent of the fellowship is to provide additional support to individuals who are engaged in any area of clinical and/or translational cancer research in order to further the development of their careers and enhance their future success in an academic discipline. The AACI fellowship will provide a one-year non-renewable grant to support post-doctoral training to individuals who have completed at least one year of training in any field of oncology and have at least one year of training remaining at an AACI member institution. Interested candidates should forward a letter of support from their mentor and their 4-page NIH biosketch to Gillian Todd by Friday, December 13.
Internal Deadline: December 13
External Deadline: February 3, 2014
AACR-Thomas J. Bardos Science Education Awards for Undergraduate Students
The AACR is pleased to offer AACR-Thomas J. Bardos Science Education Awards for Undergraduate Students for participation in two consecutive AACR Annual Meetings. Available to full-time, third-year undergraduate students majoring in science, these two-year awards are intended to inspire young science students to enter the field of cancer research and provide a unique educational opportunity for these students in the development of their careers in science.
Deadline: December 13
Audrey Meyer Mars International Fellowships in Clinical Oncology
The purpose of the Audrey Meyer Mars International Fellowship in Clinical Oncology is to provide one year of advanced training in clinical oncology at participating cancer centers in the United States to qualified physicians and dentists from other countries, particularly countries where advanced training is not readily available. Applications for training in basic cancer research will not be accepted for the award. Training will be conducted at one of the United States National Cancer Institute designated cancer centers participating in the program, including the Case Comprehensive Cancer Center.
Deadline: February 1, 2014
MARK YOUR CALENDARS
5th Annual NCRM Scientific Retreat
Registration is open for the 5th Annual NCRM Scientific Retreat that will be held Monday, December 2 at the Museum of Contemporary Art (MOCA). This year's retreat will showcase the many scientific highlights in stem cell and regenerative medicine happening within NCRM as well as engage in interactive panel discussions that will develop into new ideas for promising projects of tomorrow.
The retreat will conclude with poster presentations, and all attendees are invited to enjoy a cocktail reception while gathering around a network of leaders in stem cell and regenerative medicine. All are invited to submit abstracts to be included in the NCRM Retreat Poster Sessions. Please submit your abstract using the online registration form.